Frontlight ResearchEarly access
CompletedNo phase
mHealth for Breast Cancer Survivors With Insomnia
Key facts
- Who runs it
- Medstar Health Research Institute
- Where
- Washington D.C., United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 76 people enrolled
- Started
- 5 Apr 2022
- Ended
- 15 Dec 2023
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Faster Asleep Smart Speaker Program
- Faster Asleep Website
- Record updated
- 24 January 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Willingness to maintain a consistent dosing pattern if currently taking sleep medications or using cannabis for sleep
- Females; Age 18+
- Self-reported or documented diagnosis of breast cancer stage I-III or stage IV ECOG 0-1
- Completed curative treatment (surgery, radiation, chemotherapy) > 3 months prior to enrollment [ongoing adjuvant therapy permitted]
- Has not undergone other behavioral sleep treatment within the prior 12 months
- Score greater than or equal to 8 on the Insomnia Severity Index
- Able to understand and speak English
Who cannot take part
- Bi-polar disorder, schizophrenia, initiation of psychological treatment within three months, alcohol or drug abuse in the prior year (Alcohol >2 drinks/day or consuming 5+ drinks in a single day in the prior month). (Moderate ADHD, depression and anxiety will not be exclusion criteria.)
- Shift-work in the prior three months or anticipated during the study time
- Diagnosed, untreated obstructive sleep apnea syndrome, narcolepsy, restless leg syndrome, periodic limb movement disorder, delayed sleep phase syndrome, central apnea
- Planned regular travel out of time zone (>1 hour) during the study period
- Currently or planning to become pregnant during the study period
Where in United States
- MedStar Washington Hospital CenterWashington D.C., United States
About the trial
What the trial wants to find out
The aim of this study is to determine the impact of the voice-activated smart speaker CBT-I components on insomnia symptoms among breast cancer survivors using a randomized clinical trial.
The 2 groups in the trial
- Voice-Activated Smart Speaker ProgramTreatment being tested
Faster Asleep
Treatment: Faster Asleep Smart Speaker Program
- WebsiteExisting treatment, for comparison
Faster Asleep Website
Treatment: Faster Asleep Website
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Testing mHealth Delivery of Cognitive Behavioral Therapy for Insomnia to Breast Cancer Survivors
- Publications
- Cognitive behavioural therapy for insomnia in people with cancer.The Cochrane database of systematic reviews, 2025
- Voice-Activated Cognitive Behavioral Therapy for Insomnia: A Randomized Clinical Trial.JAMA network open, 2024
- A novel voice interactive sleep log: concurrent validity with actigraphy and sleep diaries.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2024
- Testing delivery of components of cognitive behavioral therapy for insomnia to breast cancer survivors by smart speaker: a study protocol.BMC medical informatics and decision making, 2022
- Record updated
- 24 January 2025